• Phase 3 Trials Show GSK’s Nucala Can Reduce Exacerbations in Specific COPD Patients
  • FDA Approves Triple Combination, Trelegy Ellipta, as Maintenance Therapy for COPD
  • Triple Combo Inhaler Trimbow More Effective than Utibron for COPD, Chiesi Trial Finds
  • Once-a-day Triple Combo Inhaler for COPD Patients Favored for Approval in EU
  • Combination of Verona’s RPL554 and Spiriva Improves COPD Lung Function, Phase 2a Trial Shows
  • Bellerophon Announces Positive Results for INOpulse Therapy for Pulmonary Hypertension Associated with COPD
  • Endobronchial Valves Demonstrate Improved Lung Function in Patients with Severe Emphysema
  • Pulmatrix Out-licenses PUR0200, an Inhaled COPD Therapy, to Speed Its Development in US
  • Sensitization to a Fungus May Cause Bronchiectasis in Patients with COPD, Study Indicates
  • Virtual Model Identifies Factors Contributing to Lung Dysfunction in Mice with COPD
  • Propeller Health, GSK Expand Collaboration for COPD and Asthma Inhaler Devices
  • Bariatric Surgery in Obese COPD Patients Lowers Risk of Hospitalization, Study Finds